A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence

Category Primary study
Registry of TrialsITMCTR
Year 2020
This article has no abstract
Epistemonikos ID: acdee4bfffe689cb6eee7d8d5c0572f617102fce
First added on: Oct 03, 2023